QuiaPEG Pharmaceuticals Holding AB (publ) QUIA.ST Stock
QuiaPEG Pharmaceuticals Holding AB (publ) Price Chart
QuiaPEG Pharmaceuticals Holding AB (publ) QUIA.ST Financial and Trading Overview
Contents
- QuiaPEG Pharmaceuticals Holding AB (publ) Price Chart
- QuiaPEG Pharmaceuticals Holding AB (publ) QUIA.ST Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of QuiaPEG Pharmaceuticals Holding AB (publ)
- Q&A For QuiaPEG Pharmaceuticals Holding AB (publ) Stock
| QuiaPEG Pharmaceuticals Holding AB (publ) stock price | 0.09 SEK |
| Previous Close | 0.01 SEK |
| Open | 0.01 SEK |
| Bid | 0.01 SEK x N/A |
| Ask | 0.01 SEK x N/A |
| Day's Range | 0.01 - 0.02 SEK |
| 52 Week Range | 0.0076 - 0.19 SEK |
| Volume | 20.28M SEK |
| Avg. Volume | 37.54M SEK |
| Market Cap | 21.87M SEK |
| Beta (5Y Monthly) | 0.906896 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 30, 2017 |
| 1y Target Est | N/A |
QUIA.ST Valuation Measures
| Enterprise Value | 15.95M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.92277 |
| Price/Book (mrq) | 1.48 |
| Enterprise Value/Revenue | 2.861 |
| Enterprise Value/EBITDA | -1.284 |
Trading Information
QuiaPEG Pharmaceuticals Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.906896 |
| 52-Week Change | -87.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 SEK |
| 52 Week Low | 0.0076 SEK |
| 50-Day Moving Average | 0.01 SEK |
| 200-Day Moving Average | 0.07 SEK |
QUIA.ST Share Statistics
| Avg. Volume (3 month) | 37.54M SEK |
| Avg. Daily Volume (10-Days) | 121.25M SEK |
| Shares Outstanding | 1.22B |
| Float | 228.81M |
| Short Ratio | N/A |
| % Held by Insiders | 10.51% |
| % Held by Institutions | 4.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -283.35% |
| Gross Margin | 59.81% |
| EBITDA Margin | -222.92% |
Management Effectiveness
| Return on Assets (ttm) | -41.82% |
| Return on Equity (ttm) | -1650.69% |
Income Statement
| Revenue (ttm) | 5.57M SEK |
| Revenue Per Share (ttm) | 0.03 SEK |
| Quarterly Revenue Growth (yoy) | 4.39% |
| Gross Profit (ttm) | 3.33M SEK |
| EBITDA | -12426000 SEK |
| Net Income Avi to Common (ttm) | -20089000 SEK |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.57M SEK |
| Total Cash Per Share (mrq) | 0.01 SEK |
| Total Debt (mrq) | 15.15M SEK |
| Total Debt/Equity (mrq) | 628.41 SEK |
| Current Ratio (mrq) | 0.64 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18178000 SEK |
| Levered Free Cash Flow (ttm) | -15071625 SEK |
Profile of QuiaPEG Pharmaceuticals Holding AB (publ)
| Country | Sweden |
| State | N/A |
| City | Uppsala |
| Address | Uppsala Business Park |
| ZIP | 754 50 |
| Phone | 46 7 06 93 12 53 |
| Website | https://www.quiapeg.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, engages in the research, development, and commercialization biopharmaceutical products for the treatment of metabolic disorders. The company develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.
Q&A For QuiaPEG Pharmaceuticals Holding AB (publ) Stock
What is a current QUIA.ST stock price?
QuiaPEG Pharmaceuticals Holding AB (publ) QUIA.ST stock price today per share is 0.09 SEK.
How to purchase QuiaPEG Pharmaceuticals Holding AB (publ) stock?
You can buy QUIA.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for QuiaPEG Pharmaceuticals Holding AB (publ)?
The stock symbol or ticker of QuiaPEG Pharmaceuticals Holding AB (publ) is QUIA.ST.
Which industry does the QuiaPEG Pharmaceuticals Holding AB (publ) company belong to?
The QuiaPEG Pharmaceuticals Holding AB (publ) industry is Biotechnology.
How many shares does QuiaPEG Pharmaceuticals Holding AB (publ) have in circulation?
The max supply of QuiaPEG Pharmaceuticals Holding AB (publ) shares is 1.49B.
What is QuiaPEG Pharmaceuticals Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
QuiaPEG Pharmaceuticals Holding AB (publ) PE Ratio is now.
What was QuiaPEG Pharmaceuticals Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
QuiaPEG Pharmaceuticals Holding AB (publ) EPS is -0.03 SEK over the trailing 12 months.
Which sector does the QuiaPEG Pharmaceuticals Holding AB (publ) company belong to?
The QuiaPEG Pharmaceuticals Holding AB (publ) sector is Healthcare.
QuiaPEG Pharmaceuticals Holding AB (publ) QUIA.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North All-Share EUR FIRSTNORTHEUR | 101.73 EUR 111.2 USD |
-1.09
|
— — | 101.46 EUR 110.91 USD | 103.05 EUR 112.65 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1850.16 SEK 180.6 USD |
-1.05
|
— — | 1846.86 SEK 180.28 USD | 1872.89 SEK 182.82 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1526.6 EUR 1668.78 USD |
-1.16
|
— — | 1522.28 EUR 1664.06 USD | 1548.19 EUR 1692.38 USD | — - | — — |
| First North Health Care PI FN20PI | 938.08 EUR 1025.45 USD |
-1.59
|
— — | 934.39 EUR 1021.42 USD | 959.34 EUR 1048.69 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 124.63 SEK 12.17 USD |
-0.98
|
— — | 124.43 SEK 12.15 USD | 126.01 SEK 12.3 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.79 DKK 14.92 USD |
-1.08
|
— — | 101.52 DKK 14.89 USD | 103.1 DKK 15.12 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1978.51 SEK 193.13 USD |
-1.05
|
— — | 1974.98 SEK 192.78 USD | 2002.82 SEK 195.5 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1632.46 EUR 1784.5 USD |
-1.16
|
— — | 1627.85 EUR 1779.46 USD | 1655.55 EUR 1809.74 USD | — - | — — |
| First North Health Care GI FN20GI | 942.4 EUR 1030.17 USD |
-1.59
|
— — | 938.69 EUR 1026.12 USD | 963.75 EUR 1053.51 USD | — - | — — |
- {{ link.label }} {{link}}